ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNG Synairgen Plc

4.675
0.155 (3.43%)
25 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.155 3.43% 4.675 4.35 5.00 - 25,623 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.52 9.1M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.52p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.10 million. Synairgen has a price to earnings ratio (PE ratio) of -0.52.

Synairgen Share Discussion Threads

Showing 4951 to 4974 of 99175 messages
Chat Pages: Latest  199  198  197  196  195  194  193  192  191  190  189  188  Older
DateSubjectAuthorDiscuss
23/4/2020
23:23
Thanks..I'll regret my all out post in the morning. I know you understand my perspective being Ex-RAF like me. Me and booze have a have a habit of joyfully chatting! :-)
dovey21
23/4/2020
22:56
Dovey21, best wishes to your wife and her team. I am a NHS responder and Samaritan volunteer. Important we all do what we can to support the frontline much like the RAF.
rafboy
23/4/2020
22:17
Yes..sorry! Very unlike me. This crisis strikes a chord. I'm as desperate as many for the 'solution' ?
dovey21
23/4/2020
22:14
>> dovey

Poignant post!

nobbygnome
23/4/2020
22:13
Correct. I have put my money where my mouth is but would be saying the same if it was a private company in which I couldn’t buy shares.
nobbygnome
23/4/2020
22:11
I really didn't expect you to disengage your brain. But I have never seen you so confident in a share. You have in all boards/shares clearly stated your trading approach. But I think you would favour this, over others to pass the trial, irrespective of your holding, feel free to correct me.
l0ngterm
23/4/2020
22:10
The 400 patients documented in the protocol have been discussed before ad nauseam. The initial study is a pilot in 100 patients and the other 300 are there if they have to proceed to another larger trial. This was confirmed to me by Richard.

But also as I have said ad nausam I expect conditional approval on the back of the ongoing trial if the results are good.

nobbygnome
23/4/2020
21:55
That should read..I believe in the UK and UK scientists. It's the UK that will provide the world with the solution. We're good at solutions...just not good at managing it!! :-)...I'll shut up now..cabin fever and wine! :-)
dovey21
23/4/2020
21:54
Crookie, wonder if the "OR" in the trial protocol gave SNG flexibility in case they couldnt recruit for hosp pt's......which I believe they have achieved.

As this is early intervention, it would make perfect sense to provide this to anyone showing early infections or even as preventive measure for "at risk" ? small battery nebuliser designed for use at home /nursing homes....anywhere.

141jaffa
23/4/2020
21:42
Gilead antiviral drug remdesivir flops in first COVID trialhttps://www.google.co.uk/amp/s/amp.ft.com/content/0a4872d1-4cac-4040-846f-ce32daa09d99Let's hope SNG001 does the trick.
spqstrader
23/4/2020
21:39
From lse board...


Among these IFNs, IFN- ?? was already found to strongly inhibit the replication of other corona viruses, such as SARS-CoV, in cell culture, while IFN-?? and ?? were shown to be less effective in this context [211]. There are evidences that patients with higher susceptibility to develop Acute respiratory distress syndrome (ARDS) show indeed deficiency of IFN- ??. 

likya123
23/4/2020
21:35
I can’t see results before end of May they need to get it right to ensure no hold up at the next stage. Nobby looking at the link I posted the criteria is the same for all treatments and is in line with WHO scale was this the same for the COPD trials do you think? Assuming they would know the WHO guidelines and fancy their chances that it will meet the criteria to be successful.
crookie3634
23/4/2020
21:31
There is clearly a further trial/bolt on to the current one based on Richards interview and the link I provided earlier, suggests a home trial. When will news of that drop? I would expect them to confirm when they have recruited all patients and advise a further announcement of the results in due course. Sounds like there might be other bits to come inbetween. Interest Notts is only on its 3rd patient after 10 days and Birmingham is done in a week. 10 sites 100 patients all recruited by end of April?
crookie3634
23/4/2020
21:26
Earliest third week of May but I saw somewhere today the beginning of June was more likely.
nobbygnome
23/4/2020
21:22
Nobby, very wise except you or anyone else apart from the powers that be know when the results are?

You first calculated after 12 weeks but we now all know this has been fast tracked and classified as "urgent" by the NHIR after 2 weeks of the trial starting.

We also are seeing what appears to be very fast or even full recruitment of patients already.

You also correctly acknowledged earlier today that Richard said in his interview that updates will be given in the intermediate term.

"Also interesting that they will update the market with timings of the trial. We can look forward to those announcements"


Therefore I think you already agree that results will be much sooner than any of us anticipated and may miss selling a third of your holding which I think will be the very best outcome as ofcourse I believe Synairgen may have very well hit the jackpot of all jackpots here!

likya123
23/4/2020
21:22
But just to carry on I don't think it is entirely binary. The COPD trial might produce a positive result even if SG016 doesn't. Plus of course there is the fibrosis drug so SNG is not a one trick pony.
nobbygnome
23/4/2020
21:20
3. Patients admitted to hospital due to the severity of their COVID-19 disease OR non-hospitalised patients from high-risk co-morbidity groups such as the >65-years of age, or those with hypertension, cardiovascular disease, diabetes or a chronic lung condition

It’s in this paragraph OR NON-HOSPITALISED looks like it has the scope and Richards interview confirmed it.

crookie3634
23/4/2020
21:18
>> Ali

Thanks for the praise. It is gratefully received and let's hope that many people are saved by this drug.

nobbygnome
23/4/2020
21:17
>> L0ngterm

My average buy price is about 19p so I intend to sell a third of my holding before the results hopefully in the 80s but will take whatever price I can ultimately. That means I will be running for free and whatever will be will be.

I am confident but that doesn't mean I disengage my brain so you just have to take some off the table ahead of the results IMHO

nobbygnome
23/4/2020
21:16
Longterm , the protocols are going out of the window mate.
peachie 74
23/4/2020
21:15
hxxps://ctag-support.org.uk/docs/antivirals.pdf

This is also worth a read, an internalNHS document that contains our treatment.

crookie3634
23/4/2020
21:13
Longterm, I would sell all your shares in the morning as don't think this share is for you.

Nobby, please do the honours..

likya123
23/4/2020
21:13
I just wanted to say thank you for perhaps the most informative and useful thread I have read for many years - I am no expert in this - I have seen the impact of the virus on a young person and the thought that you could potentially prevent this at home is incredibly. Thank you all - especially Nobby.
ali g2
23/4/2020
21:12
TVM Crookie V interesting:

This indicates it could be used outside hospitals in the trial:


Patients admitted to hospital due to the severity of their COVID-19 disease OR non-hospitalised patients from high-risk co-morbidity groups such as the >65-years of age, or those with hypertension, cardiovascular disease, diabetes or a chronic lung condition


This is interesting as it means that the trial is on patients newly diagnosed:

Principal exclusion criteria
1. > 24 hours after confirmation of SARS-CoV-2 infection

toffeeman
Chat Pages: Latest  199  198  197  196  195  194  193  192  191  190  189  188  Older

Your Recent History

Delayed Upgrade Clock